- Date
- Tuesday 20 October 2026
- Time
- 07h30 to 12h30 IST
- Where
- Online, broadcast from Seoul
- Hosted by
- Element Biosciences
Four things to take away.
Turn a hit into a story you can act on
CRISPR and drug screening with Cytos™, which reads morphology, protein expression, guide RNA and the 3' transcriptome from the same cell.
See variants in the tissue they came from
Direct In Sample Sequencing applied to spatial variant detection and cell typing in tissue.
Scale up without compromise
VITARI™, Element's newest platform, with its latest performance data.
Hear from labs using the platforms
Talks spanning multiomics and sequencing applications, and time with Element's senior staff for your questions.
Who should attend: PIs, core facility and NGS lab directors, translational and clinical research leads, and biopharma R&D or technology assessment teams.
From Element, and from labs across Asia Pacific.
Molly He, PhD
CEO & Co-founder
Element Biosciences
Michael Previte, PhD
CTO, SVP, Advanced Research & Cofounder
Element Biosciences
Omshree Shetty, PhD
Scientific Officer
Tata Memorial Hospital
Mark Adams, PhD
Associate Professor
QUT Centre for Genomics and Personalised Health
Hang-Rae Kim, PhD
Professor
Samsung Precision Genome Medicine Institute
Inkyung Jung, PhD
Associate Professor
KAIST
Akinori Kanai, PhD
Project Associate Professor
University of Tokyo
Eun-Chong Lee, PhD
Research Assistant Professor
Yonsei University College of Medicine
Kenta Shirasawa, PhD
Head of Laboratory
Kazusa DNA Research Institute
Speakers' views are their own. Element Biosciences products are for Research Use Only and not for use in diagnostic procedures.